VEA
FLNA

Virtus ETF Advisers’s Filana Therapeutics FLNA Stock Holding History

Virtus ETF Advisers’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,634
Closed -$136K – 498
2024
Q3 		$136K Buy
4,634
+83
+2% +$1.91K 0.06% 337
2024
Q2 		$56.2K Buy
4,551
+1,672
+58% +$35.2K 0.03% 441
2024
Q1 		$58.4K Sell
2,879
-196
-6% -$4.52K 0.03% 416
2023
Q4 		$69.2K Sell
3,075
-832
-21% -$17.6K 0.04% 421
2023
Q3 		$65K Sell
3,907
-386
-9% -$7.65K 0.04% 396
2023
Q2 		$105K Buy
4,293
+2,005
+88% +$48.3K 0.06% 355
2023
Q1 		$55.2K Sell
2,288
-887
-28% -$24.6K 0.03% 426
2022
Q4 		$93.8K Sell
3,175
-1,092
-26% -$39.2K 0.05% 440
2022
Q3 		$178K Buy
4,267
+26
+0.6% +$702 0.07% 331
2022
Q2 		$119K Buy
4,241
+942
+29% +$23.8K 0.04% 387
2022
Q1 		$123K Sell
3,299
-200
-6% -$8.47K 0.06% 261
2021
Q4 		$153K Buy
3,499
+701
+25% +$36.8K 0.06% 342
2021
Q3 		$174K Sell
2,798
-153
-5% -$12.8K 0.08% 303
2021
Q2 		$252K Buy
+2,951
New +$158K 0.1% 208

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Virtus ETF Advisers's FLNA Position: Q4 2024 in Review

Virtus ETF Advisers sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 4,634 shares — an estimated $136K sold.

Virtus ETF Advisers first reported a position in FLNA in Q2 2021 and held it in 14 quarters. The position peaked at $252K in Q2 2021. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Virtus ETF Advisers reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Virtus ETF Advisers sold 4,634 Filana Therapeutics shares in Q4 2024, an estimated $136K.
  • Virtus ETF Advisers first reported a position in Filana Therapeutics in Q2 2021 and held it in 14 quarters.
  • Virtus ETF Advisers's Filana Therapeutics position peaked at $252K in Q2 2021.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Virtus ETF Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.